Drug interactions
Brexucabtagene autoleucel + Natalizumab
Severity: Major
Brexucabtagene autoleucel and Natalizumab: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Natalizumab adds to the immunosuppression of CAR T-cell therapy, which already causes prolonged cytopenias and low immunoglobulins. Natalizumab also carries a risk of progressive multifocal leukoencephalopathy that may be heightened by additional immune compromise.
What this interaction means in plain words
Brexucabtagene autoleucel and Natalizumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Brexucabtagene autoleucel belongs to Oncology; Natalizumab belongs to Gastrointestinal Tract.
Why it happens
Additive immunosuppression from impaired lymphocyte trafficking and CAR T-related immune depletion.
What to do
Avoid concurrent use where possible and time natalizumab discontinuation with the treating specialists. Monitor for infection and neurological signs suggesting PML.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Brexucabtagene autoleucel and Natalizumab, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Natalizumab
- Natalizumab + Vedolizumab Contraindicated
- Axicabtagene ciloleucel + Natalizumab Major
- Baricitinib + Natalizumab Major
- Belatacept + Natalizumab Major
- Cabazitaxel + Natalizumab Major
- Certolizumab pegol + Natalizumab Major
Other interactions of Brexucabtagene autoleucel
Frequently asked questions
Can I take Brexucabtagene autoleucel with Natalizumab?
MediHelp rates the interaction as major. Brexucabtagene autoleucel and Natalizumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Natalizumab adds to the immunosuppression of CAR T-cell therapy, which already causes prolonged cytopenias and low immunoglobulins. Natalizumab also carries a risk of progressive multifocal leukoencephalopathy that may be heightened by additional immune compromise.
How serious is the interaction between Brexucabtagene autoleucel and Natalizumab?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use where possible and time natalizumab discontinuation with the treating specialists. Monitor for infection and neurological signs suggesting PML.
What other medicines interact with Natalizumab?
MediHelp also lists interactions of Natalizumab with, for example, Vedolizumab, Axicabtagene ciloleucel, Baricitinib. The full list is on the Natalizumab page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
